T2 Biosystems, Inc. (TTOO)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2014Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Goldman Sachs Group Inc 10% Owner 4,201,582 Aug 3, 2021
Goldman Sachs & Co. Llc 10% Owner 4,201,582 Aug 3, 2021
Jones Adrian M Director 4,201,582 Aug 3, 2021
MBD Advisors, L.L.C. 10% Owner 4,157,240 Dec 11, 2015
Broad Street Principal Investments, L.L.C. 10% Owner 4,157,240 Dec 11, 2015

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 4, 2024 Jan 2, 2025 LIEBMAN SEYMOUR Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Adams Laura Lee Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 CUMMING JOHN W Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Gibbs Michael Terrence General Counsel Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Toft Robin Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Sperzel John J III Officer Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Elsbree David B Director Neutral 52.5 - 0.00% -
Nov 4, 2024 Jan 2, 2025 Sprague John M CFO Neutral 52.5 - 0.00% -
Sep 13, 2024 Sep 17, 2024 Elsbree David B Director Sell 27.5 -55 -68.75% $133.1
May 9, 2024 May 13, 2024 CR Group L.P. 10% Owner Neutral 52.5 - 0.00% -
May 3, 2024 May 7, 2024 CR Group L.P. 10% Owner Neutral 90.0 +4,748,335 115.68% -
Apr 12, 2024 Apr 16, 2024 CR Group L.P. 10% Owner Neutral 90.0 +3,280,618 398.03% -
Feb 24, 2024 Feb 27, 2024 Sperzel John J III Officer Neutral 52.5 - 0.00% -
Feb 24, 2024 Feb 27, 2024 Sprague John M CFO Neutral 52.5 - 0.00% -
Feb 24, 2024 Feb 27, 2024 Gibbs Michael Terrence General Counsel Neutral 52.5 - 0.00% -
Feb 20, 2024 Feb 20, 2024 Gibbs Michael Terrence General Counsel Neutral 52.5 - 0.00% -
Feb 20, 2024 Feb 20, 2024 Sprague John M CFO Neutral 52.5 - 0.00% -
Feb 20, 2024 Feb 20, 2024 Sperzel John J III Officer Neutral 52.5 - 0.00% -
Feb 20, 2024 Feb 20, 2024 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Feb 14, 2024 Feb 16, 2024 CR Group L.P. 10% Owner Neutral 52.5 - 0.00% -
Jan 1, 2024 Jan 3, 2024 Toft Robin Director Neutral 52.5 - 0.00% -
Nov 8, 2023 Nov 28, 2023 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Feb 20, 2023 Nov 28, 2023 Giffin Brett A. Chief Commercial Officer Sell 30.0 -537 -14.97% $349.1
Oct 18, 2023 Oct 20, 2023 Adams Laura Lee Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 Elsbree David B Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 Toft Robin Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 CUMMING JOHN W Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 Adams Laura Lee Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 LIEBMAN SEYMOUR Director Neutral 52.5 - 0.00% -
Sep 15, 2023 Oct 11, 2023 Bernard Thierry Director Neutral 52.5 - 0.00% -
Sep 27, 2023 Sep 29, 2023 CR Group L.P. 10% Owner Sell 17.5 -13,130,147 -100.00% $2.3M
Sep 26, 2023 Sep 28, 2023 CR Group L.P. 10% Owner Sell 17.5 -5,392,920 -29.11% $1.1M
Sep 25, 2023 Sep 27, 2023 CR Group L.P. 10% Owner Sell 22.5 -250,000 -1.33% $62.5K
Sep 22, 2023 Sep 26, 2023 CR Group L.P. 10% Owner Sell 17.5 -5,079,344 -21.29% $1.3M
Sep 21, 2023 Sep 25, 2023 CR Group L.P. 10% Owner Sell 17.5 -6,338,211 -20.99% $1.9M
Sep 20, 2023 Sep 22, 2023 CR Group L.P. 10% Owner Sell 17.5 -7,753,710 -20.43% $2.4M
Sep 19, 2023 Sep 21, 2023 CR Group L.P. 10% Owner Sell 17.5 -10,401,466 -21.51% $3.8M
Jan 1, 2023 Aug 16, 2023 Bernard Thierry Director Neutral 52.5 - 0.00% -
Jan 1, 2023 Aug 16, 2023 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Aug 6, 2023 Aug 16, 2023 Toft Robin Director Neutral 52.5 - 0.00% -
Jul 3, 2023 Jul 14, 2023 CR Group L.P. 10% Owner Neutral 52.5 - 0.00% -
Jul 3, 2023 Jul 6, 2023 CR Group L.P. 10% Owner Neutral 90.0 +48,345,798 100.00% -
Jul 6, 2023 CR Group L.P. 10% Owner Neutral 52.5 - 0.00% -
Mar 28, 2023 Apr 6, 2023 Gibbs Michael Terrence General Counsel Sell 42.5 -239 -3.49% $115
Mar 24, 2023 Apr 5, 2023 Gibbs Michael Terrence General Counsel Neutral 52.5 - 0.00% -
Mar 24, 2023 Mar 28, 2023 Gibbs Michael Terrence General Counsel Neutral 52.5 - 0.00% -
Oct 18, 2022 Mar 9, 2023 Adams Laura Lee Director Neutral 52.5 - 0.00% -
Feb 20, 2023 Mar 9, 2023 Giffin Brett A. Chief Commercial Officer Sell 15.0 -537 -38.97% $349.1
Feb 20, 2023 Mar 9, 2023 Sprague John M CFO Sell 25.0 -2,693 -17.42% $1.7K
Feb 20, 2023 Mar 9, 2023 Gibbs Michael Terrence General Counsel Sell 20.0 -3,730 -24.17% $2.3K
Feb 20, 2023 Mar 9, 2023 Sperzel John J III CEO Sell 20.0 -9,773 -24.03% $6.2K
Nov 8, 2022 Nov 22, 2022 Giffin Brett A. Chief Commercial Officer Sell 27.5 -1,292 -36.45% $2.3K
Oct 11, 2022 Oct 13, 2022 Bernard Thierry Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 Elsbree David B Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 Toft Robin Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 Adams Laura Lee Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 CUMMING JOHN W Director Neutral 52.5 - 0.00% -
Oct 11, 2022 Oct 13, 2022 LIEBMAN SEYMOUR Director Neutral 52.5 - 0.00% -
Aug 6, 2022 Aug 9, 2022 Toft Robin Director Neutral 52.5 - 0.00% -
Aug 6, 2022 Aug 9, 2022 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Aug 6, 2022 Aug 9, 2022 Bernard Thierry Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 Bernard Thierry Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 Toft Robin Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 LIEBMAN SEYMOUR Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 Elsbree David B Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 CUMMING JOHN W Director Neutral 52.5 - 0.00% -
Jun 25, 2022 Jun 28, 2022 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Apr 7, 2022 Apr 11, 2022 Sperzel John J III CEO Buy 91.3 +30,000 15.64% $15K
Apr 8, 2022 Apr 11, 2022 Barclay Alec Chief Operations Officer Buy 85.0 +12,951 7.66% $6.5K
Apr 7, 2022 Apr 11, 2022 Gibbs Michael Terrence General Counsel Buy 85.0 +10,000 6.38% $4.9K
Apr 8, 2022 Apr 11, 2022 Sprague John M CFO Buy 85.0 +10,000 7.02% $4.8K
Apr 8, 2022 Apr 11, 2022 Giffin Brett A. Chief Commercial Officer Buy 90.0 +10,600 100.00% $5.2K
Feb 26, 2022 Mar 30, 2022 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Mar 30, 2022 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Mar 14, 2022 Mar 30, 2022 Barclay Alec Chief Operations Officer Sell 47.5 -11,428 -6.33% $4.2K
Feb 24, 2022 Mar 29, 2022 Sprague John M CFO Sell 46.3 -55,008 -27.87% $24.7K
Feb 21, 2022 Mar 29, 2022 Sprague John M CFO Sell 47.5 -3,775 -6.81% $1.8K
Mar 24, 2022 Mar 28, 2022 Gibbs Michael Terrence General Counsel Sell 47.5 -8,790 -5.31% $3.9K
Feb 24, 2022 Mar 28, 2022 Gibbs Michael Terrence General Counsel Sell 46.3 -76,867 -34.07% $34.5K
Feb 21, 2022 Mar 28, 2022 Gibbs Michael Terrence General Counsel Sell 47.5 -5,275 -6.19% $2.5K
Feb 24, 2022 Feb 28, 2022 Sprague John M CFO Sell 46.3 -55,008 -28.77% $24.7K
Feb 24, 2021 Feb 28, 2022 Barclay Alec Chief Operations Officer Sell 46.3 -88,878 -35.89% $39.9K
Feb 24, 2022 Feb 28, 2022 Gibbs Michael Terrence General Counsel Sell 46.3 -76,867 -35.65% $34.5K
Feb 24, 2022 Feb 28, 2022 Sperzel John J III Officer Sell 42.5 -141,560 -42.47% $63.5K
Feb 21, 2021 Feb 23, 2022 Barclay Alec Chief Operations Officer Sell 47.5 -5,275 -6.25% $2.5K
Feb 21, 2022 Feb 23, 2022 Sprague John M CFO Sell 47.5 -3,775 -7.66% $1.8K
Feb 21, 2022 Feb 23, 2022 Gibbs Michael Terrence General Counsel Sell 47.5 -5,275 -7.01% $2.5K
Feb 20, 2022 Feb 23, 2022 Giffin Brett A. Chief Commercial Officer Neutral 52.5 - 0.00% -
Feb 20, 2022 Feb 23, 2022 Sperzel John J III Officer Neutral 52.5 - 0.00% -
Feb 20, 2022 Feb 23, 2022 Ahuja Aparna Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 6, 2022 Jan 10, 2022 Ahuja Aparna Chief Medical Officer Sell 13.8 -61,988 -36.55% $29.8K
Jan 5, 2022 Jan 6, 2022 Ahuja Aparna Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 1, 2022 Jan 4, 2022 Toft Robin Director Neutral 52.5 - 0.00% -
Jan 1, 2022 Jan 4, 2022 Saunders Ninfa Director Neutral 52.5 - 0.00% -
Jan 1, 2022 Jan 4, 2022 LIEBMAN SEYMOUR Director Neutral 52.5 - 0.00% -
Jan 1, 2022 Jan 4, 2022 Bernard Thierry Director Neutral 52.5 - 0.00% -